LATENT MEMBRANE PROTEIN-1 OF EBV IN THE RECOGNITION OF INFECTED B LYMPHOCYTES
LATENT MEMBRANE PROTEIN-1 OF EBV IN THE RECOGNITION OF INFECTED B LYMPHOCYTES
批准号:
3839151
负责人:
Zoya B Kurago
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
爱泼斯坦-巴尔病毒是疱疹病毒家族的成员,
感染大多数人类,并可能无限期地留在人体内,
通常以潜伏感染的形式出现。EB病毒可以改变B-
并使其永生。据说EB病毒是
包括恶性肿瘤在内的许多疾病的原因
免疫功能受损的病人。
T淋巴细胞在控制人类免疫缺陷病毒感染中起主要作用。
转化的B细胞群体。一些潜伏的病毒蛋白
已知在识别受感染的B-病毒方面很重要
杀伤T淋巴细胞所致的淋巴细胞。
该项目旨在研究T细胞溶细胞性克隆,即
识别潜伏膜蛋白-1(LMP-1)的部分
主要由I类分子呈递给T细胞受体
组织相容性复合分子(MHC)。大约100
针对EB病毒的细胞溶解T细胞克隆已经产生。
感染了B细胞,并部分鉴定了。
英文摘要
Epstein-Barr virus (EBV), a member of the herpes virus family,
infects most humans and may remain in the body indefinitely,
generally in the form of a latent infection. EBV can transform B-
lymphocytes and cause their immortalization. EBV is said to be the
cause of a number of diseases including malignancies in the
immunocompromised patients.
T-lymphocytes are of primary importance in controlling the
transformed B-cell population. Some of the latent viral proteins
are known to be important in the recognition of infected B-
lymphocytes by killer T-lymphocytes.
This project is designed to study T-cell cytolytic clones, that
recognize portions of the Latent Membrane Protein-1 (LMP-1), which
are presented to the T-cell receptor by Class I major
histocompatibility complex molecules (MHC). Approximately 100
cytolytic T-cell clones have already been generated against EBV-
infected B-cells and partially characterized.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NATURAL KILLER CELLS MAY RECOGNIZE HLA CLASS I-PEPTIDE COMBINATIONS
-
批准号:3775601
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Zoya B Kurago
-
依托单位:
海外基金